The Swoop® system is an innovative medical imaging device created by Hyperfine. Our company was founded in 2014 by Dr. Jonathan Rothberg. Holding over 100 patents, Dr. Rothberg is the visionary behind high-speed DNA sequencing and Butterfly iQ, the world’s best-selling point-of-care ultrasound (POCUS).
At Hyperfine, Rothberg and his team of scientists and engineers set out to put MR imaging within reach of every patient regardless of location—in any healthcare facility in any country across the globe.
While the Hyperfine team retained the fundamental principles of MRI (magnetic resonance imaging) and its core components, they turned just about everything else on its head. The team designed the Swoop system for simplicity while leveraging advances in image-centric computing and deep learning and the ten-million-fold increase in computing power since the invention of MRI technology over 40 years ago.
Hyperfine produced its first images within a year of its founding, and since then, it has rapidly advanced image quality and functionality. FDA cleared in 2020, the Swoop system is the world’s first easy-to-use bedside MR imaging system.
Meet Our Executive Team
Jonathan Rothberg, PhD
Serial entrepreneur, founded and invented massively parallel DNA sequencing, semiconductor sequencing, and ultrasound-on-a-chip (Butterfly Network); awarded the National Medal of Technology and Innovation by US President Barack Obama; Yale University PhD, MS, MPhil; Carnegie Mellon BS.
Successful CEO, Chairman, board member, entrepreneur, and investor, involved in more than 20 medtech startup, growth, and public companies with market valuations totaling over $20 billion and benefitting over 20 million patients with the therapies and diagnostics they deliver. Ernst & Young Entrepreneur Of The Year. Goldman Sachs 100 Most Intriguing Entrepreneurs. University of Southern California Magna Cum Laude BSBA. Harvard Business School MBA.
President and CEO
Twenty-five years building and leading teams at digital surgery, digital health ecosystem, surgical robotics, and medical imaging and diagnostic startups and Fortune 500 companies, including Apple, Verb Surgical, Abbott Medical Optics, OptiMedica, Intuitive Surgical, Xradia, and Varioscale. Awarded patents in x-ray imaging, medical endoscopy, and laser surgery applications. University of Kansas BS; University of Colorado, Boulder MS.
Chief Financial Officer
Twenty years experience in the financial and banking industry with a prior background in manufacturing systems and mechanical engineering. Previous leadership experience with Halio Inc., Mizuho Securities, and Citigroup. UCLA Anderson School of Management MBA in Banking, Corporate, Finance, and Securities Law.
Chief Product Officer
Formerly head of Surgical and Implantable Devices and founding member of Verily Life Science, formerly known as Google Life Sciences. Expertise in medical devices, medtech, and imaging. Senior positions at Google, Abbott Medical Optics, Proximie, and OptiMedica. Patents and publications in medical imaging, medical image processing, intraoperative imaging, surgical technology, and surgical workflow optimization. UC Berkeley and UC San Francisco PhD in Bioengineering. Georgia Institute of Technology BS in Biomedical Engineering.
Khan Siddiqui, M.D.
Chief Medical Officer /
Chief Strategy Officer
Serial entrepreneur; board-certified radiologist with leadership experience at Johns Hopkins University and University of Maryland; American College of Radiology Informatics Commission; Microsoft R&D leader; Founder, CTO, and Chief Medical Officer of higi.
Chief Operating Officer
20+ years leading R&D and start-ups at Thermo Fisher Scientific, Life Technologies / Ion Torrent, Lucent Technologies / Sycamore Networks / Sirocco Systems, Sahara Networks; experience at Raytheon, GTE, Motorola; University of Rhode Island BS EE / MBA.
Chief People Officer
Seventeen years of human resources experience rapidly scaling organizations while nurturing unique cultures and creating exceptional employee experiences. Previous leadership roles include Mesa Biotech/Thermo Fisher Scientific and CrossFit, Inc. Licensed attorney in California. Columbia University BA in Political Science; Cleveland Marshall College of Law Juris Doctorate.
Twenty-five years of legal experience in healthcare, life sciences law, and autonomous vehicles. Previous leadership roles include Alphabet/Waymo, Genentech, CVS Caremark, and Blue Shield of California. She was also in private practice in Washington, DC. Illinois Wesleyan University BA in International Business Administration; George Washington University Law School Juris Doctorate.
Senior Vice President Global Sales
Twenty-five years sales and marketing experience with healthcare startups and Fortune 500 companies focused on neurosurgical medical and imaging devices. Extensive experience building early stage commercial organizations. Previously, Senior Vice President Global Sales and Marketing at IMRIS, VP Sales and Marketing at Clearpoint Neuro (formerly MRI Interventions), and Medtronic, Regional Sales Director. Ohio State University BSBA.
Michael Poole, PhD
Co-founder at Hyperfine and 17 years of MRI development in academia and industry, including fellowships at Forschungszentrum Jülich, University of Queensland, and the Sir Peter Mansfield MR Centre; University of Nottingham PhD.
Michael Brant-Zawadzki, M.D.
Senior Physician Executive at Hoag Health Network in Newport Beach, California. He holds the Ron and Sandi Simon Executive Medical Director Endowed Chair of the Pickup Family Neurosciences Institute at Hoag, having led the Institute from its inception. Dr. Brant-Zawadzki is a Gold Medal recipient from the Society of Magnetic Resonance in Medicine and has authored over 250 papers and numerous textbooks, including the first text on Magnetic Resonance Imaging of the Central Nervous System.
Fady Charbel, M.D.
Head of the Department of Neurosurgery and Chief Clinical Service Director, Neurovascular Program, University of Illinois at Chicago. Dr. Charbel currently holds eight patents and is the developer and co-inventor of both the Charbel Micro-flowprobe®, designed for use in intracranial surgery, and the NOVA® system, which measures blood flow in the brain as part of diagnosis and treatment of cerebrovascular disease. He is an internationally recognized clinical expert, researcher, and educator in stroke, brain aneurysms, and complex cerebral tumors.
Murat Gunel, M.D.
Chair of the Department of Neurosurgery and Chief of Neurosurgery at Yale New Haven Health System. He is a pioneer and innovator in advanced neurosurgical techniques and serves as the Co-Director of the Yale Program on Neurogenetics. In addition to being a clinical expert in neurovascular surgery, Dr. Gunel leads a research laboratory that completed the two largest genome-wide associate studies (GWAS) aimed at better understanding the genetic risk for intracranial aneurysms.
Brian Litt, M.D.
Professor of Neurology and Professor of Bioengineering at the University of Pennsylvania Perelman School of Medicine and Director of the Penn Epilepsy Center. Dr. Litt is also the Director of The Center for Neuroengineering and Therapeutics, a cutting-edge initiative between the Perelman School of Medicine and the School of Engineering and Applied Sciences that serves as a catalyst across the University of Pennsylvania to develop partnerships with industry and create innovative technology and devices.
Michael Modic, M.D.
Senior Vice President of Population Health and Professor of Radiology and Radiological Sciences at Vanderbilt University School of Medicine. He is a member of the Board of Trustees of the Cleveland Clinic Foundation and recipient of the Gold Medal of the Society of Magnetic Resonance in Imaging. Dr. Modic practiced for over 35 years at the Cleveland Clinic, serving as Chairman of the Division of Radiology, Chairman of the Neurological Institute, and Chief Clinical Transformation Officer. Here he oversaw the opening of Cleveland Clinic imaging sites across the U.S. and the expansion of its clinical presence in several cities around the world.
Shahid Nimjee, M.D.
Co-director of Ohio State Wexner Medical Center’s Comprehensive Stroke Center and an Associate Professor at the Wexner School of Medicine, Ohio State University. He is a practicing neurological surgeon with dual training in both open and endovascular neurosurgery. Dr. Nimjee leads a translational research laboratory focused on discovering more effective and safer therapies to treat patients suffering from stroke and other thrombotic diseases.
Roderick Pettigrew, M.D.
CEO of EnHealth and Executive Dean for EnMed at Texas A&M University. He is the founding director of the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health. He was elected to the National Academy of Medicine in 2007 and the National Academy of Engineering in 2010 for his use of MRI in human blood-flow studies and for leading advancements in bioengineering research and education.
Michael Schulder, M.D.
Vice Chair of Neurosurgery at North Shore University Hospital and Long Island Jewish Medical Center. He is also Director of the Brain Tumor Center of the Northwell Neuroscience Institute and a practicing neurosurgeon for more than 30 years. Dr. Schulder is an expert in a full range of brain surgery techniques and has been a pioneer in utilizing new image guidance methods for neurosurgery, including the incorporation of low-field and intraoperative MRI.
Eliot Siegel, M.D.
Professor and Vice Chair at the University of Maryland School of Medicine, Department of Diagnostic Radiology. Under his leadership as the Chief of Radiology and Nuclear Medicine, the Veterans Affairs Maryland Healthcare System became the first 100% filmless radiology department in the world. He is a fellow of the American College of Radiology and the Society of Imaging Informatics in Medicine and on the Society of Computer Applications in Radiology Board of Directors. He has written over 200 articles and book chapters and given hundreds of presentations related to computer applications in imaging and medicine.
James Smirniotopoulos, M.D.
Professorial Lecturer at George Washington University and former Professor and Chair of Radiology at the Uniformed Services University of the Health Sciences. Previously, he was Chief of Neuroradiology at the Armed Forces Institute of Pathology in Washington D.C., which was responsible for training radiology residents throughout the U.S. He continues to teach Neuroradiology in the successor Radiologic-Pathology course sponsored by the ACR. He is a Special Volunteer at the National Library of Medicine at the NIH; and, is Chief Editor of the MedPix™ Radiology Database and Teaching File. His is the recipient of the ASNR 2021 Gold Medal.
Hyperfine began from our personal experience with the extraordinary power – and numerous challenges – of conventional MRI. Despite being one of the safest and most informative imaging modalities available, MRI is accessible to just a small percentage of patients. Even in the countries where it is present, MRI is expensive, complicated, and stressful for the patient.
With our first commercial product, the Swoop® Portable MR Imaging SystemTM, Hyperfine created the next generation of magnetic resonance imaging (MRI) devices by addressing the challenges of conventional MRI and bringing MR imaging to the patient’s bedside.
Our mission is to provide affordable and accessible imaging, sensing, and guided robotic intervention to revolutionize healthcare for people worldwide. We are developing an ecosystem covering the entire care continuum, with hardware, software, consumables, and applications powered by artificial intelligence.
What Others Say
[We] believe that the global MRI market is on the brink of a new era as word of the once ‘mythical’ affordable and portable MRI spreads. With its groundbreaking design, Hyperfine’s portable MRI can extend access to cost-effective imaging and, subsequently, its clinical utility and healthcare value across medical applications, clinical specialties and settings, and geographical regions worldwide.
-Frost & Sullivan, 2020
Awards & Recognition
Fast Company Magazine World Changing Ideas honorable mention in two categories: North America and Health
Hyperfine is part of the 4Catalyzer family of companies. 4Catalyzer is a health technology incubator with facilities in Connecticut, New York City, Palo Alto, and Taiwan. The mission of 4Catalyzer is to make healthcare more accessible and maximize societal impact.